Brief: Tango Therapeutics Q2 Basic EPS USD -0.24
07/08/2024 12:00
Aug 07 (Reuters) - Tango Therapeutics Q2 net income USD -25.551 million vs. IBES estimate USD -36.1 million. * Q2 operating income USD -29.552 million vs. IBES estimate USD -38.4 million * Q2 operating expenses USD 49.427 million
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,